WOBURN, Mass. — Covaris, Inc., the leader in focused acoustic technologies for the life sciences, has been awarded an International Collaborative Industry Program (ICIP) grant from the Massachusetts Life Sciences Center for the development of a one-step sample preparation device for use in molecular diagnostics, as part of a $640,000 collaborative project with Coris BioConcept […]

VÉLIZY-VILLACOUBLAY, France — Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions announces the extension of the tender offer by its wholly owned indirect subsidiary, 3DS Acquisition Corp., to purchase all outstanding shares of Accelrys, Inc. (NASDAQ: ACCL) (Accelrys) […]

BOTHELL, Wash. — BioLife Solutions, Inc. (OTCQB: BLFS) today announced that is has closed a public offering of units for gross proceeds of approximately $15.4 million at a price of $4.30 per unit, completed the conversion of $14.3 million of debt into equity and received approval to list its common stock on the NASDAQ Capital […]

Salt Lake City, UT — BioFire Defense, LLC of Salt Lake City, UT announced today that it was awarded the Next Generation Diagnostic System (NGDS) Technology Development contract by the US Department of Defense (DoD) after 12 months of competitive prototyping. The 8 year $240M biodefense program is managed by the Joint Program Executive Office’s […]

MADISON, Wis. — Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the fourth quarter and for the fiscal year ended December 31, 2013. “We continue to be pleased with the revenue growth of the company. Total revenues […]

BILLERICA, Mass. –– RainDance Technologies, Inc., an innovative genomics tools company making molecular testing of complex diseases more standardized and readily available, today announced that it has closed a $16.5 million Series E financing round extension. New investors include GE Ventures and Northgate Capital; all existing financial investors also participated in this round of financing. […]

SAN FRANCISCO, Calif.,– Bell Biosystems Inc. announced two major developments in its pioneering efforts to create synthetic organelles for life science research: Series A financing and acceptance into the Janssen Labs Program at QB3@953 in San Francisco, the premier life science startup incubator in the Bay Area. The new funds are being used to scale […]

ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX) today announced it has sold 70,000 shares of a newly authorized Series A Convertible Preferred Stock for $3.5 million. The Series A Preferred Stock carries a cumulative annual 3% preferred dividend or $1.50 per share, in preference to BioTime common shares. Each share of Series A Preferred Stock […]

LEXINGTON, Mass. — Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that it was one of the 33 recipients of the Massachusetts Life Sciences Center tax awards. The Life Sciences Tax Incentive Program authorizes up to $25 million in tax incentives each […]